Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma

Journal:

The New England Journal of Medicine

Published:

2025-06-04

DOI:

10.1056/nejmoa2505133

Affiliations:

26

Authors:

26

Go to article

Institutions	Authors	Share
Hôpital Saint-Louis, France	3.000000	0.12
Communauté d’universités et établissements de Toulouse (COMUE de Toulouse), France	1.500000	0.06
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), France	1.500000	0.06
Rennes University Hospital (CHU Rennes), France	1.000000	0.04
Dijon University Hospital, France	1.000000	0.04
CHU de Poitiers, France	1.000000	0.04
Centre Hospitalier Régional Universitaire de TOURS (CHRU de Tours), France	1.000000	0.04
Lyon University Hospital (HCL), France	1.000000	0.04
Hôpital Haut-Lévêque, France	1.000000	0.04
Institut Paoli-Calmettes (IPC), France	1.000000	0.04
University Hospital Nantes (CHU de Nantes), France	1.000000	0.04
University of Nantes, France	1.000000	0.04
Hôpital Avicenne, France	1.000000	0.04
University Hospital of Liege, Belgium	1.000000	0.04
AP-HP Pitié-Salpêtrière Hospital, France	1.000000	0.04
CHU Caen, France	1.000000	0.04
Centre Léon Bérard (CLB), France	1.000000	0.04
Alps Grenoble University Hospital (CHU Grenoble Alpes), France	1.000000	0.04
CHU Henri-Mondor, France	1.000000	0.04
Centre Hospitalier Universitaire de Lille (CHU Lille), France	1.000000	0.04
CHU Clermont-Ferrand, France	1.000000	0.04
Centre Hospitalier de la Côte Basque (CHCB), France	1.000000	0.04
Saint Antoine Hospital, France	1.000000	0.04

Interested in Oncology and Carcinogenesis?